Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy

References

• Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1):35–47.
   PubMed Web of Science ®Google Scholar
• Wasilewski-Masker K, Mertens AC, Patterson B, et al. Severity of health conditions identified in a pediatric cancer survivor program. Pediatr Blood Cancer. 2010;54(7):976–982.
   PubMed Web of Science ®Google Scholar
• Kooijmans EC, Bökenkamp A, Tjahjadi NS, et al. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database Syst Rev. 2019;3(3):Cd008944.
   PubMedGoogle Scholar
• van der Velde M, Matsushita K, Coresh J, Chronic Kidney Disease Prognosis Consortium, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79(12):1341–1352.
   PubMed Web of Science ®Google Scholar
• Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629–637.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Group K. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl. 2013;3:1–150.
   Web of Science ®Google Scholar
• Vinge E, Lindergard B, Nilsson-Ehle P, et al. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest. 1999;59(8):587–592.
   PubMed Web of Science ®Google Scholar
• Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38(10):1933–1953.
   PubMed Web of Science ®Google Scholar
• Ferguson TW, Komenda P, Tangri N. Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens. 2015 May;24(3):295–300.
   PubMed Web of Science ®Google Scholar
• Risch L, Herklotz R, Blumberg A, et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001;47(11):2055–2059.
   PubMed Web of Science ®Google Scholar
• Ye Y, Gai X, Xie H, et al. Impact of thyroid function on serum cystatin C and estimated glomerular filtration rate: a cross-sectional study. Endocr Pract. 2013;19(3):397–403.
   PubMed Web of Science ®Google Scholar
• den Bakker E, Gemke R, van Wijk JAE, et al. Combining GFR estimates from cystatin C and creatinine-what is the optimal mix? Pediatr Nephrol. 2018;33(9):1553–1563. Sep
   PubMed Web of Science ®Google Scholar
• Grubb A, Nyman U, Bjork J. Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine. Scand J Clin Lab Invest. 2012;72(1):73–77. Feb
   PubMed Web of Science ®Google Scholar
• Bökenkamp A, Herget-Rosenthal S, Bökenkamp R. Cystatin C, kidney function and cardiovascular disease. Pediatr Nephrol. 2006;21(9):1223–1230.
   PubMed Web of Science ®Google Scholar
• Lees JS, Welsh CE, Celis-Morales CA, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nat Med. 2019;25(11):1753–1760.
   PubMed Web of Science ®Google Scholar
• Grubb A, Lindstrom V, Jonsson M, et al. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome. Scand J Clin Lab Invest. 2015;75(4):333–340.
   PubMed Web of Science ®Google Scholar
• Grubb A. Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options. Clin Biochem. 2020;83:12–20.
   PubMed Web of Science ®Google Scholar
• Åkesson A, Lindström V, Nyman U, et al. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities. Scand J Clin Lab Invest. 2020;80(5):412–422. Sep
   PubMed Web of Science ®Google Scholar
• Herou E, Dardashti A, Nozohoor S, et al. The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratio. Scand J Clin Lab Invest. 2019;79(3):167–173.
   PubMed Web of Science ®Google Scholar
• Dardashti A, Nozohoor S, Grubb A, et al. Shrunken pore syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting. Scand J Clin Lab Invest. 2016;76(1):74–81.
   PubMed Web of Science ®Google Scholar
• Christensson A, Grubb A, Molvin J, et al. The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population - the HARVEST study. Scand J Clin Lab Invest. 2016;76(7):568–574.
   PubMed Web of Science ®Google Scholar
• den Bakker E, Gemke RJ, van Wijk JA, et al. Evidence for shrunken pore syndrome in children. Scand J Clin Lab Invest. 2020;80(1):32–38.
   PubMed Web of Science ®Google Scholar
• Kamps WA, Bökkerink JP, Hählen K, et al. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch childhood leukemia study group protocol ALL-7 (1988-1991). Blood. 1999;94(4):1226–1236.
   PubMed Web of Science ®Google Scholar
• Kamps WA, Bökkerink JP, Hakvoort-Cammel FG, et al. BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996). Leukemia. 2002;16(6):1099–1111.
   PubMed Web of Science ®Google Scholar
• Klijs B, Scholtens S, Mandemakers JJ, et al. Representativeness of the LifeLines cohort study. PLoS One. 2015;10(9):e0137203.
   PubMed Web of Science ®Google Scholar
• Scholtens S, Smidt N, Swertz MA, et al. Cohort profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2015;44(4):1172–1180.
   PubMed Web of Science ®Google Scholar
• Grubb A, Blirup-Jensen S, Lindstrom V, IFCC Working Group on Standardisation of Cystatin C (WG-SCC), et al. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med. 2010;48(11):1619–1621.
   PubMed Web of Science ®Google Scholar
• Inker LA, Eneanya ND, Coresh J, Chronic Kidney Disease Epidemiology Collaboration, et al. New creatinine- and cystatin C-Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749.
   PubMed Web of Science ®Google Scholar
• Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. The new England journal of medicine. N Engl J Med. 2012;367(1):20–29.
   PubMed Web of Science ®Google Scholar
• Pottel H, Hoste L, Dubourg L, et al. An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant. 2016;31(5):798–806.
   PubMed Web of Science ®Google Scholar
• Pottel H, Delanaye P, Schaeffner E, et al. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant. 2017;32(3):497–507.
   PubMed Web of Science ®Google Scholar
• Björk J, Grubb A, Sterner G, et al. Revised equations for estimating glomerular filtration rate based on the Lund-Malmö study cohort. Scand J Clin Lab Invest. 2011; 71(3):232–239.
   PubMed Web of Science ®Google Scholar
• Grubb A, Horio M, Hansson LO, et al. Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin Chem. 2014;60(7):974–986.
   PubMed Web of Science ®Google Scholar
• Purde MT, Nock S, Risch L, et al. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Transl Res. 2016; 169:80–90 e1-2.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Lindström V, Schmidt C, et al. Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process. Scand J Clin Lab Invest. 2007;67(6):612–618.
   PubMed Web of Science ®Google Scholar
• Kristensen K, Wide-Swensson D, Schmidt C, et al. Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia. Acta Obstet Gynecol Scand. 2007;86(8):921–926.
   PubMed Web of Science ®Google Scholar
• Sasser JM, Murphy SR, Granger JP. Emerging drugs for preeclampsia–the endothelium as a target. Expert Opin Emerg Drugs. 2015;20(4):527–530.
   PubMed Web of Science ®Google Scholar
• Wijerathne H, Langston JC, Yang Q, et al. Mechanisms of radiation-induced endothelium damage: Emerging models and technologies. Radiother Oncol. 2021; 58:21–32.
   Google Scholar
• Breitz H. Clinical aspects of radiation nephropathy. Cancer Biother Radiopharm. 2004;19(3):359–362.
   PubMed Web of Science ®Google Scholar
• Clausen CT, Hasle H, Holmqvist AS, et al. Hyperthyroidism as a late effect in childhood cancer survivors - an adult life after childhood cancer in scandinavia (ALiCCS) study. Acta Oncol. 2019;58(2):227–231.
   PubMed Web of Science ®Google Scholar
• George SA, Effinger KE, Meacham LR. Endocrine sequelae in childhood cancer survivors. Endocrinol Metab Clin North Am. 2020;49(4):565–587.
   PubMed Web of Science ®Google Scholar